These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 1307623

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Serum hepatocyte growth factor levels in liver diseases: clinical implications.
    Shiota G, Okano J, Kawasaki H, Kawamoto T, Nakamura T.
    Hepatology; 1995 Jan; 21(1):106-12. PubMed ID: 7806142
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of hepatocyte growth factor in patients with biliary atresia.
    Hsieh CS, Huang LT, Lee SY, Huang CC, Lee CL, Chuang JH, Chen CL.
    J Pediatr Surg; 2008 Jul; 43(7):1333-7. PubMed ID: 18639691
    [Abstract] [Full Text] [Related]

  • 5. Changes in serum levels of growth factors in healthy individuals after living related liver donation.
    Efimova EA, Glanemann M, Nussler AK, Schumacher G, Settmacher U, Jonas S, Nussler N, Neuhaus P.
    Transplant Proc; 2005 Mar; 37(2):1074-5. PubMed ID: 15848626
    [Abstract] [Full Text] [Related]

  • 6. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
    Wu FS, Zheng SS, Wu LJ, Ding W, Ma ZM, Wang ZM, Teng LS, Zhao WH.
    Zhonghua Wai Ke Za Zhi; 2006 May 01; 44(9):603-8. PubMed ID: 16784653
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Significance of serum hepatocyte growth factor levels in patients with hepatocellular carcinoma undergoing hepatic resection.
    Chau GY, Lui WY, Chi CW, Chau YP, Li AF, Kao HL, Wu CW.
    Eur J Surg Oncol; 2008 Mar 01; 34(3):333-8. PubMed ID: 17218078
    [Abstract] [Full Text] [Related]

  • 9. Serum transforming growth factor-alpha level can be a parameter for evaluating liver regeneration after partial hepatectomy in patients with liver cancer.
    Tomiya T, Hayashi S, Yanase M, Umeda N, Tani M, Yamada S, Masaki N, Ogata I, Fujiwara K.
    Semin Oncol; 1997 Apr 01; 24(2 Suppl 6):S6-14-S6-17. PubMed ID: 9151911
    [Abstract] [Full Text] [Related]

  • 10. Anti-hepatocyte growth factor antibody inhibits hepatocyte proliferation during liver regeneration.
    Burr AW, Toole K, Chapman C, Hines JE, Burt AD.
    J Pathol; 1998 Jul 01; 185(3):298-302. PubMed ID: 9771484
    [Abstract] [Full Text] [Related]

  • 11. Serum concentrations of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in C-viral chronic liver diseases.
    Yamagamim H, Moriyama M, Matsumura H, Aoki H, Shimizu T, Saito T, Kaneko M, Shioda A, Tanaka N, Arakawa Y.
    Cancer; 2002 Aug 15; 95(4):824-34. PubMed ID: 12209727
    [Abstract] [Full Text] [Related]

  • 12. Portal serum human hepatocyte growth factor levels after partial hepatectomy.
    Higaki I, Yamazaki O, Matsuyama M, Horii K, Kawai S, Hirohashi K, Kinoshita H.
    Hepatogastroenterology; 1999 Aug 15; 46(26):1078-82. PubMed ID: 10370670
    [Abstract] [Full Text] [Related]

  • 13. Serum hepatocyte growth factor and vascular endothelial growth factor in children with acute liver failure.
    Aw MM, Mitry RR, Hughes RD, Dhawan A.
    J Pediatr Gastroenterol Nutr; 2007 Feb 15; 44(2):224-7. PubMed ID: 17255836
    [Abstract] [Full Text] [Related]

  • 14. Increased level of serum hepatocyte growth factor/scatter factor in liver cancer is associated with tumor metastasis.
    Junbo H, Li Q, Zaide W, Yunde H.
    In Vivo; 1999 Feb 15; 13(2):177-80. PubMed ID: 10363175
    [Abstract] [Full Text] [Related]

  • 15. Hepatocyte growth factor levels in Croatian healthy and alcoholic liver cirrhosis patients.
    Antoljak N, Topić E, Duvnjak M, Vrkić N, Zuntar I.
    Coll Antropol; 2001 Jun 15; 25(1):341-8. PubMed ID: 11787560
    [Abstract] [Full Text] [Related]

  • 16. Association between serum hepatocyte growth factor and survival in untreated hepatocellular carcinoma.
    Vejchapipat P, Tangkijvanich P, Theamboonlers A, Chongsrisawat V, Chittmittrapap S, Poovorawan Y.
    J Gastroenterol; 2004 Dec 15; 39(12):1182-8. PubMed ID: 15622483
    [Abstract] [Full Text] [Related]

  • 17. Hepatocyte growth factor concentration in rat bile is affected by hepatic resection volume and external biliary drainage.
    Hayata A, Takeuchi E, Nagino M, Yoshida S, Nimura Y.
    J Surg Res; 1999 Jul 15; 85(1):71-6. PubMed ID: 10383840
    [Abstract] [Full Text] [Related]

  • 18. Hepatocyte growth factor (HGF) in patients with hepatitis B and meningitis.
    Ozden M, Kalkan A, Demirdag K, Denk A, Kilic SS.
    J Infect; 2004 Oct 15; 49(3):229-35. PubMed ID: 15337340
    [Abstract] [Full Text] [Related]

  • 19. Human hepatocyte growth factor in bile: an indicator of posthepatectomy liver function in patients with biliary tract carcinoma.
    Takeuchi E, Nimura Y, Nagino M, Kurumiya Y, Maeda A, Kamiya J, Kondo S, Kanai M, Miyachi M, Uesaka K, Yoshida S.
    Hepatology; 1997 Nov 15; 26(5):1092-9. PubMed ID: 9362347
    [Abstract] [Full Text] [Related]

  • 20. Hepatocyte growth factor, blood clearance, organ uptake, and biliary excretion in normal and partially hepatectomized rats.
    Appasamy R, Tanabe M, Murase N, Zarnegar R, Venkataramanan R, Van Thiel DH, Michalopoulos GK.
    Lab Invest; 1993 Mar 15; 68(3):270-6. PubMed ID: 8450646
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.